Cargando…

Oral melphalan as a treatment for platinum-resistant ovarian cancer

A large number of drugs have been used to treat recurrent ovarian cancer, yet there are few data that guide the physician's choice. Typically, the decision to re-treat with platinum-based therapy depends on the progression-free interval. However, the optimum agent for the treatment of platinum-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, J, Jayson, G C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741128/
https://www.ncbi.nlm.nih.gov/pubmed/12799622
http://dx.doi.org/10.1038/sj.bjc.6601044

Ejemplares similares